Research

Mixed

A composite panel of seven circulating senescence-associated secretory phenotype (SASP) proteins (GDF15, FAS, OPN, TNFR1, ACTIVIN A, CCL3, and IL-15) serves as a superior biomarker for predicting adverse postoperative outcomes and biological age compared to chronological age or single-protein markers.

This research suggests that measuring a specific set of 7 proteins in the blood (GDF15, FAS, OPN, TNFR1, ACTIVIN A, CCL3, and IL-15) can provide a more accurate assessment of biological age and surgical risk than chronological age. For older adults, this panel may help identify those at higher risk for complications after surgery, potentially guiding pre-operative care and post-operative monitoring.

GoodSupportsHIGH confidence
A panel of 7 SASP factors composed of growth differentiation factor 15 (GDF15), TNF receptor superfamily member 6 (FAS), osteopontin (OPN), TNF receptor 1 (TNFR1), ACTIVIN A, chemokine (C-C motif) ligand 3 (CCL3), and IL-15 predicted adverse events markedly better than a single SASP protein or age.
Marissa Schafer et al. · JCI Insight · 2020

Why this rating

The study uses multiple cohorts (biobank, aortic stenosis, ovarian cancer) and robust statistical modeling (GBM, ROC AUC), but is observational and limited to specific surgical populations.

Source

The senescence-associated secretome as an indicator of age and medical risk

Marissa Schafer et al. · JCI Insight · 2020

DOI 10.1172/jci.insight.133668

cohort · n=343Cited 377×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →